Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
NCT ID: NCT05994976
Last Updated: 2025-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2023-10-17
2028-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inflammatory Cells From Various Pathologies
NCT02270411
Sebum Collection and Skin Barrier Function Analysis
NCT03112876
Evaluation of the Role of Propionibacterium Acnes in the Inflammatory Lesions Associated With Acne Vulgaris
NCT01929057
A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients
NCT01688531
Acne Vulgaris Related Microbiology and Serology
NCT04056598
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy volunteers
Healthy adults
Blood samples collection
biomarkers and optional genetic analysis
Oral samples collection
biomarkers analysis
Hair samples collection
biomarkers analysis
Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis
Skin surface material samples
biomarkers analysis
Drainage fluid samples collection
biomarkers analysis
Stool samples collection
biomarkers analysis
Acne
Adult subjects aged 18 to 45 years old with acne
Blood samples collection
biomarkers and optional genetic analysis
Oral samples collection
biomarkers analysis
Hair samples collection
biomarkers analysis
Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis
Skin surface material samples
biomarkers analysis
Drainage fluid samples collection
biomarkers analysis
Stool samples collection
biomarkers analysis
AD
Adult subjects with Atopic Dermatitis (AD)
Blood samples collection
biomarkers and optional genetic analysis
Oral samples collection
biomarkers analysis
Hair samples collection
biomarkers analysis
Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis
Skin surface material samples
biomarkers analysis
Drainage fluid samples collection
biomarkers analysis
Stool samples collection
biomarkers analysis
CHE
Adult subjects with Chronic Hand Eczema (CHE)
Blood samples collection
biomarkers and optional genetic analysis
Oral samples collection
biomarkers analysis
Hair samples collection
biomarkers analysis
Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis
Skin surface material samples
biomarkers analysis
Drainage fluid samples collection
biomarkers analysis
Stool samples collection
biomarkers analysis
HS
Adult subjects with Hidradenitis suppurativa (HS)
Blood samples collection
biomarkers and optional genetic analysis
Oral samples collection
biomarkers analysis
Hair samples collection
biomarkers analysis
Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis
Skin surface material samples
biomarkers analysis
Drainage fluid samples collection
biomarkers analysis
Stool samples collection
biomarkers analysis
PPP
Adult subjects with Palmoplantar pustulosis (PPP)
Blood samples collection
biomarkers and optional genetic analysis
Oral samples collection
biomarkers analysis
Hair samples collection
biomarkers analysis
Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis
Skin surface material samples
biomarkers analysis
Drainage fluid samples collection
biomarkers analysis
Stool samples collection
biomarkers analysis
Psoriasis
Adult subjects with Psoriasis
Blood samples collection
biomarkers and optional genetic analysis
Oral samples collection
biomarkers analysis
Hair samples collection
biomarkers analysis
Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis
Skin surface material samples
biomarkers analysis
Drainage fluid samples collection
biomarkers analysis
Stool samples collection
biomarkers analysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood samples collection
biomarkers and optional genetic analysis
Oral samples collection
biomarkers analysis
Hair samples collection
biomarkers analysis
Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis
Skin surface material samples
biomarkers analysis
Drainage fluid samples collection
biomarkers analysis
Stool samples collection
biomarkers analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Subject is willing to participate and is capable of giving informed consent. Note: Consent must be obtained prior to any study-related procedures.
2. Subject must be willing to comply with all study procedures and must be available for the duration of the study.
Healthy volunteers:
3. Male or female subject aged 18 years or older, at the time of consent.
4. Subject is in good general health, according to the investigator's judgment.
Subjects with Acne:
5. Male or female subject aged 18 to 45 years old, inclusive, at the time of consent.
Subjects with AD:
6. Male or female subject aged 18 years or older, at the time of consent.
7. Subject has clinically confirmed diagnosis of active AD, according to Hanifin and Rajka criteria.
Subjects with CHE:
8. Male or female subject aged 18 years or older, at the time of consent.
9. Subject has at least a 6-month history of CHE before Screening (information obtained from medical chart or subject's physician, or directly from the subject).
Subjects with HS:
10. Male or female subject aged 18 years or older, at the time of consent.
11. Subject has a clinically confirmed diagnosis of active HS with a disease duration of ≥ 6 months before screening as determined by the investigator through subject interview and/or review of the medical history.
Subjects with PPP:
12. Male or female subject aged 18 years or older at the time of consent.
13. Subject has at least a 6-month history of PPP as defined by the presence of pustules on palms and/or soles, but without evidence of infection on palms and soles (information obtained from medical chart or subject's physician, or directly from the subject).
Subjects with psoriasis:
14. Male or female subject aged 18 years or older, at the time of consent.
Exclusion Criteria
1. Subject is a female who is pregnant or who is planning to become pregnant during the study.
2. Subject has a history of skin disease or presence of skin condition that, in the opinion of the investigator, would interfere with the study assessments.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Innovaderm Research Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Bissonnette, MD
Role: PRINCIPAL_INVESTIGATOR
Innovaderm Research Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Innovaderm Research Inc.
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INNO-5034
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.